Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dal-Ré, Rafael
636  Ergebnisse:
Personensuche X
?
1

Revisión por pares: consideraciones a las propuestas de Can..:

Dal-Ré, Rafael
Anales de Pediatría.  100 (2024)  4 - p. 311-312 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Peer-review: Considerations to Candal-Pedreira et al.'s pro..:

Dal-Ré, Rafael
Anales de Pediatría (English Edition).  100 (2024)  4 - p. 311-312 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Challenges in conducting efficacy trials for new COVID-19 v..:

Dal-Ré, Rafael ; Bottieau, Emmanuel ; Launay, Odile..
Clinical Trials.  , 2024
Link: https://doi.org/10.1177/..
 
?
4

Adequate information about clinical trial results must be g..:

Dal-Ré, Rafael ; Caplan, Arthur L. ; Holm, Søren..
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
5

The definition of research misconduct should be stated in t..:

Dal-Ré, Rafael ; Marušić, Ana
Accountability in Research.  , 2024
Link: https://doi.org/10.1080/..
 
?
6

Is full transparency in clinical trials an achievable goal?:

Dal-Ré, Rafael
European Journal of Internal Medicine.  123 (2024)  - p. 1-3 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Is "interventional trial" a correct term to use in clinical..:

Dal-Ré, Rafael
European Journal of Clinical Pharmacology.  , 2024
Link: https://doi.org/10.1007/..
 
?
8

Voluntary transparency of sponsors of medicines clinical tr..:

Dal-Ré, Rafael
Journal of Clinical Epidemiology.  169 (2024)  - p. 111282 , 2024
Link: https://doi.org/10.1016/..
 
?
9

The Carlos III Research Institute and registration of clini..:

Dal-Ré, Rafael
Medicina Clínica (English Edition).  160 (2023)  2 - p. 94-95 , 2023
Link: https://doi.org/10.1016/..
 
?
10

'Time out'—more transparency is required in 'Just-in-time' ..:

Dal-Ré, Rafael ; Caplan, Arthur L ; Voo, Teck Chuan
European Journal of Internal Medicine.  108 (2023)  - p. 100-101 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Waivers of informed consent in research with competent part..:

Dal-Ré, Rafael
European Journal of Clinical Pharmacology.  79 (2023)  4 - p. 575-578 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Is it reasonable to label a trial as pragmatic whose invest..:

Dal-Ré, Rafael
Clinical Trials.  20 (2023)  3 - p. 319-321 , 2023
Link: https://doi.org/10.1177/..
 
?
13

Using the phases of clinical development of medicines to de..:

Dal-Ré, Rafael ; Banzi, Rita ; Cristea, Ioana A....
Journal of Clinical Epidemiology.  161 (2023)  - p. 157-163 , 2023
Link: https://doi.org/10.1016/..
 
?
14

'Pragmatic' or 'streamlined': Which term best fits the REMA..:

Dal-Ré, Rafael
European Journal of Internal Medicine.  113 (2023)  - p. 119-121 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Posting of clinical trial results and other critical inform..:

Dal-Ré, Rafael ; Mahillo-Fernández, Ignacio
European Journal of Clinical Pharmacology.  79 (2023)  10 - p. 1385-1390 , 2023
Link: https://doi.org/10.1007/..
 
1-15